Convatec

Convatec Group plc is a global medical products and technologies company based in London, England. Established in 1978, it specializes in advanced wound care, ostomy care, continence care, and infusion care. With operations in over 100 countries, Convatec has become a market leader, reporting revenues exceeding $2 billion as of 2022. The company offers a range of innovative products, including wound care dressings featuring Hydrofiber technology, which absorbs wound fluid and transforms it into a gel, and silver dressings that help reduce bacterial presence. Convatec also provides solutions for ostomy care, continence care, and infusion devices, catering to patients with chronic conditions. The company has expanded its capabilities through strategic acquisitions, including 180 Medical and Triad Life Sciences, enhancing its product offerings and research capabilities. Convatec is listed on the London Stock Exchange and is part of the FTSE 100 Index, reflecting its strong market presence and commitment to improving patient outcomes worldwide.

• Employees 11000
• Founded 1978
• Annual Revenue $2289200000
• Total Funding $1828270000